|Right ventricular obstructive hypertrophic cardiomyopathy in primary myo-adenylate deaminase deficiency.|
|Jump to Full Text|
|PMID: 21842595 Owner: NLM Status: MEDLINE|
|MyoAdenylate Deaminase Deficiency (MADD) is a relatively common metabolic disorder of the skeletal muscle. Patients with MADD usually show an impaired bioenergetic production and a clinical spectrum with either exercise-induced muscle pain, fatigue and/or rhabdomyolysis. Left ventricular hypertrophy as well as other types of cardiac involvement have been reported in patients with primary MADD. We describe herein a case of a 61-year-old woman with biochemical and genetic evidence of Myo-Adenylate Deaminase deficiency, in whom we found a right ventricular hypertrophic cardiomyopathy leading to severe outflow tract dynamic obstruction.|
|C de Gregorio; G Morabito; O Musumeci; R Donato; A Toscano|
Related Documents :
|17106175 - Clinical applications of ecg-gated myocardial perfusion spect.
19205835 - Comparison of alzheimer's disease with vascular dementia and non-dementia using specifi...
879035 - Thallium-201 imaging with color display computer system in old myocardial infarction.
20458635 - Evaluation of (99) (m)tcn-mpo as a new myocardial perfusion imaging agent in normal ...
8198205 - Alcoholic cardiomyopathy.
6247465 - The predictive value of myocardial radioisotope scanning in animals treated with doxoru...
|Type: Case Reports; Journal Article|
|Title: Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases Volume: 30 ISSN: 1128-2460 ISO Abbreviation: Acta Myol Publication Date: 2011 Jun|
|Created Date: 2011-08-16 Completed Date: 2011-09-16 Revised Date: 2013-06-28|
Medline Journal Info:
|Nlm Unique ID: 9811169 Medline TA: Acta Myol Country: Italy|
|Languages: eng Pagination: 46-8 Citation Subset: IM|
|Clinical and Experimental Department of Medicine and Pharmacology, Messina University Hospital, Messina, Italy. firstname.lastname@example.org|
|APA/MLA Format Download EndNote Download BibTex|
Cardiomyopathy, Hypertrophic / enzymology*, physiopathology, ultrasonography
Hypertrophy, Right Ventricular / complications, enzymology*, physiopathology, ultrasonography
Ventricular Outflow Obstruction / etiology*
|EC 220.127.116.11/AMP Deaminase|
Journal ID (nlm-ta): Acta Myol
Journal ID (publisher-id): Pacini
Publisher: Pacini Editore SpA
The journal and the individual contributions contained in it are protected by the copyright of Gaetano Conte Academy, Naples, Italy
Print publication date: Month: 7 Year: 2011
Volume: 30 Issue: 1
First Page: 46 Last Page: 48
PubMed Id: 21842595
Publisher Id: Pacini
|Right ventricular obstructive hypertrophic cardiomyopathy in primary Myo-Adenylate Deaminase Deficiency|
|C. DE GREGORIO|
|Clinical and Experimental Department of Medicine and Pharmacology;
1 Department of Neurosciences, Psichiatry
2 Department of Radiological Sciences, Messina University Hospital, Messina, Italy
|Correspondence: Address for correspondence: Cesare de Gregorio, Dipartimento Clinico-Sperimentale di Medicina e Farmacologia, Unità Operativa
di Cardiologia, Policlinico Universitario di Messina, viale Gazzi, 98125 Messina, Italy. Tel/Fax +39 090 2213531. E-mail: email@example.com; firstname.lastname@example.org
Myo-Adenylate Deaminase deficiency (MADD) is a relatively common metabolic disorder of the skeletal muscle firstly described in 1978 (1). The enzyme is one of the most active in the purine nucleotide cycle, playing the adenosine-5-monophosphate deamination and maintaining the high adenosine-5-triphosphate/-diphosphate/- monophosphate ratio necessary for the bionergetic metabolism of the working muscle.
Because of the variety of genetic expression of such mutant alleles, the syndrome ranges from asymptomatic carriers to patients showing exercise-induced muscle pain, fatigue, intolerance to exercise, and/or rhabdomyolysis (rare) (2-6).
We report a peculiar case of right ventricular (RV, right ventricle) hypertrophic cardiomyopathy leading to severe dynamic obstruction across the outflow tract.
A 61-year-old woman presented with a long-lasting history of diffuse myalgias, cramps at lower limbs, fatigue and exercise intolerance. Her family history was unremarkable for neuromuscular disorders, heart diseases and conventional cardiovascular risk factors.
Neurological examination showed mild proximal muscle weakness, more pronounced at lower limbs. Laboratory measurements showed mild CK elevation (397 U/l; reference range, < 200 U/l). Electromyography was unremarkable, whereas muscle biopsy revealed unspecific morphological alterations, but totally absent histochemical staining for MAD. Biochemical study on muscle homogenate also evidenced a virtual absence of MAD activity. Analysis of adenosin-monophosphate-deaminase 1 (AMPD-1) gene identified the common mutation C34T in an homozygous state, which confirmed the diagnosis of MADD.
As routinely scheduled in our neuromuscular patients, she was referred to the cardiology department for heart evaluation.
Physical examination revealed resting heart rate of 75 bpm and sitting blood pressure of 135/80 mm Hg. Intense systolic murmur (Levine grade 4) was electively heard on the pulmonary valve.
Resting ECG (Fig. 1) revealed sinus rhythm (75 bpm), normal atrio-ventricular conduction time (180 ms), right bundle branch block (QRS duration < 120 ms), high S-wave voltage in leads V4-5 and negative T-waves in leads V1-5, with no serious arrhythmias at 24-hour ECG monitoring.
Transthoracic echocardiography showed normal LV morphofunctional indices at rest, but concentric RV hypertrophy (free-wall diastolic thickness 8 mm). Global systolic function was preserved (ejection fraction ≥ 0.60) in both ventricles, with normal fractional shortening. Tricuspid and mitral annulus plane systolic excursion were 20 and 17 mm, respectively. Possible endomyocardial HT was seen in the RV outflow tract (Fig. 2, A-B) to be associated to a muscular obstruction leading to severe dynamic gradient throughout the outflow tract (peak value 60-70 mm Hg) (Fig. 2, C-D).
The patient underwent gadolinium-enhanced cardiac magnetic resonance imaging (MRI), which confirmed the RV free wall hypertrophy, but also demonstrated a giant moderator band, both leading to outflow tract occlusion (Fig. 2, E-F). No signs of RV dysplasia or delay enhancement were recognized.
This report shows a novel RV disease in a MADD patient, chiefly consisting with severe hypertrophy of the free wall and the moderator band. These morphofunctional findings may be similar to those from patients with RV arrhythmogenic dysplasia, but the lack of specific MRI findings, delay enhancement, typical premature ventricular beats, epsilon potentials at ECG and myocardial vacuolations allowed us to exclude that cardiomyopathy (9, 10).
Interestingly, prominent trabeculations into the RV, like in our patient, are quite hard to be interpreted properly. In fact, due to its irregular structure, the diagnosis of RV-HT is challenging. The criteria proposed by Jenni et al. (11) and Stollberger et al. (12) for LV-HT barely apply to the RV. As recently emphasized by Limongelli et al. (13) multiple or exaggerated trabeculations can be a normal variant of the RV, and there is no chance for both echocardiography and cardiac MRI to discriminate between the two conditions. Nevertheless, RV-HT has been described in neonatal decompensated hearts (14, 15).
The severe RV dynamic obstruction is of clinical concern because of: a) its influence on patient's symptoms (fatigue, breathlessness), b) few chances of reducing the gradient noninvasively.
In conclusion, although genetic relationships between neurological and cardiological features are not well defined, this report confirms the need for a comprehensive investigation of the heart in MADD patients, bearing in mind that the above described symptoms could be the consequence of undervalued heart failure.
The Authors are grateful to Dr. Gianluca Di Bella for his comments on cardiac magnetic resonance findings.
|1..||Fishbein WN,Armbrustmacher VM,Griffin JL. Myoadenylate deaminase deficiency: A new disease of muscleScienceYear: 1978200545548644316|
|2..||Kar NC,Pearson CM. Muscle adenylate deaminase deficiency: report of six new casesArch NeurolYear: 1981382792817224911|
|3..||Fishbein WN. Primary, secondary, and coincidental types of myoadenylate deaminase deficiencyAnn NeurolYear: 19994554754810211487|
|4..||Fishbein WN. Myoadenylate deaminase deficiency: inherited and acquired formsBiochem MedYear: 1985331581694004819|
|5..||Toscano A,Aguennouz M,Monici MC,et al. Myoadenilate deaminase deficiency: clinical, histochemical and biochemical studies in primary and "coincidental" casesItal J BiochemYear: 199746S170174|
|6..||Mercelis R,Martin JJ,Barsy T,et al. Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsiesJ NeurolYear: 19872343853893655841|
|7..||Finsterer J,Schoser B,Stollberger C. Myoadenylate deaminase gene mutation associated with left ventricular hypertrabeculationActa CardiolYear: 20045945345615368811|
|8..||Skyllouriotis ML,Marx M,Bittner RE,et al. Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndromePediatr NeurolYear: 19971761669308979|
|9..||Marcus FI,McKenna WJ,Sherrill D,et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteriaCirculationYear: 20101211533154120172911|
|10..||Bauce B,Basso C,Ramazzo A,et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutationsEur Heart JYear: 2005261666167515941723|
|11..||Jenni R,Oechslin E,Schneider J,et al. Echocardiographic and patho-anatomical characteristics of pathological noncompaction, as a distinct cardiomyopathyHeartYear: 20018666667111711464|
|12..||Stollberger C,Finsterer J. Left ventricular hypertrabeculation/ noncompactionJ Am Soc EchocardiogrYear: 2004179110014712196|
|13..||Limongelli G,Pacileo G,Calabrò P,et al. Right ventricular hypertrabeculation associated with double-outlet left ventricle: exaggeration of a normal pattern or right ventricular cardiomyopathy?J Cardiovasc MedYear: 201011193195|
|14..||Alehan D,Dogan OF. Right ventricular noncompaction in a neonate with complex congenital heart diseaseCardiol YoungYear: 20051543443616014196|
|15..||Hruda j,Sobotka-Plojhar MA,Fetter WP. Transient postnatal heart failure caused by noncompaction of the right ventricular myocardiumPediatr CardiolYear: 20052645245416374698|
Keywords: Key words Echocardiography, Myo-Adenylate Deaminase deficiency, neuromuscular disorders, right ventricular disease, right ventricular hypertrabeculation, right ventricular hypertrophic cardiomyopathy.
Previous Document: Desmin A213V substitution represents a rare polymorphism but not a mutation and is more prevalent in...
Next Document: [Successful rituximab therapy for MALT lymphoma complicating cryoglobulinemic glomerulonephritis].